Comparing two medications for second-trimester abortion
Treatments studied
Part of Women’s health & pregnancy clinical trials.
This trial tests two different medicines (Mifepristone vs Misoprostol) to see which works better for ending a pregnancy in the second trimester (12–16 weeks). It is for people who are pregnant with one baby and have no major health issues that could affect safety.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You speak English or Spanish.
- You are between 12 weeks and 0 days and 16 weeks and 6 days pregnant with one baby.
- You have not had more than two C-sections.
- You do not have placenta previa (the placenta covering the cervix) or other placental problems.
- You are not taking blood-thinning medication and have not had a cervical stitch (cerclage) in place.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two medications—letrozole plus misoprostol versus misoprostol alone—to see which is more effective for ending a pregnancy in the second trimester (14–20 weeks) after the fetus has stopped developing. The goal is to find a safer, more comfortable method for women who need this procedure.
This trial compares the effectiveness of two medications (letrozole and mifepristone with misoprostol) to help the body pass pregnancy tissue after a silent miscarriage. It may help women who prefer medical treatment over waiting or surgery.
This study tests whether taking letrozole or mifepristone before medication helps the medical abortion work better for pregnancies up to 10 weeks. You may be asked to try another method (repeat medicine or a procedure) if the first treatment does not fully work.
This study compares two ways of taking medicine (by mouth or vaginal insertion) to safely manage a miscarriage that was discovered on ultrasound between 8–16 weeks of pregnancy. The goal is to see which method works better and causes fewer side effects.
This trial compares different waiting times between two medicines used to manage early pregnancy loss. It tests if taking the second medicine right away works as well as waiting 24 hours.
This study tests if taking only misoprostol (instead of the usual two-pill regimen) is safe and effective for ending early pregnancy. It may offer a simpler option for people up to 11 weeks pregnant.
Hear when a new Cervical Preparation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.